KHK7580
7580-003
Phase 2 small_molecule completed
Quick answer
KHK7580 for Hyperparathyroidism is a Phase 2 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KYOWA KIRIN AUSTRALIA PTY LTD
- Indication
- Hyperparathyroidism
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed